Biological activity and magnetic resonance imaging of superparamagnetic iron oxide nanoparticles-labeled adipose-derived stem cells

Stem Cell Research and Therapy

Volumn 4, Issue 2, 2013, Pages

  Fan, Jingjing ^a   Tan, Yanbin ^a   Jie, Liyong ^a   Wu, Xinying ^a   Yu, Risheng ^a   Zhang, Minming ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adipose derived stem cells; Bone marrow mesenchymal stem cells; Magnetic resonance imaging; Superparamagnetic iron oxide nanoparticles

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LABELING; CELL VIABILITY; CONTENT ANALYSIS; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOGENICITY; IN VITRO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLAST; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TRANSMISSION ELECTRON MICROSCOPY; ADIPOSE TISSUE; BONE MARROW CELL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN; MESENCHYMAL STROMA CELL; STEM CELL;

ADIPOSE TISSUE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; FERRIC COMPOUNDS; FLOW CYTOMETRY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; STEM CELLS;

EID: 84878340635     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt191     Document Type: Article

References (37)

1. Stem cells for the treatment of urinary incontinence. Staack A, Rodriguez LV, Curr Urol Rep 2011 12 41 46 10.1007/s11934-010-0155-z 21113694
2. Mesenchymal stem cells for cartilage repair in osteoarthritis. Gupta PK, Das AK, Chullikana A, Majumdar AS, Stem Cell Res Ther 2012 3 25 10.1186/scrt116 22776206
3. Stem cell therapy for the spinal cord. Donnelly EM, Lamanna J, Boulis NM, Stem Cell Res Ther 2012 3 24 10.1186/scrt115 22776143
4. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. Taléns-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, Gómez-Lechón MJ, World J Gastroenterol 2006 12 5834 5845 17007050 (Pubitemid 44594252)
5. Human adipose tissue is a source of multipotent stem cells. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH, Mol Biol Cell 2002 13 4279 4295 10.1091/mbc.E02-02-0105 12475952 (Pubitemid 35471185)
6. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005-0342 16410387 (Pubitemid 44464698)
7. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Cowan CM, Shi YY, Aalami OO, Chou YF, Mari C, Thomas R, Quarto N, Contag CH, Wu B, Longaker MT, Nat Biotechnol 2004 22 560 567 10.1038/nbt958 15077117 (Pubitemid 38585908)
8. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, Di Halvorsen Y, Storms RW, Goh B, Kilroy G, Wu X, Gimble JM, Stem Cells 2006 24 376 385 10.1634/stemcells.2005- 0234 16322640 (Pubitemid 44464807)
9. Multipotent stromal cells for autologous cell therapy approaches in the guinea pig model. Frölich K, Scherzed A, Mlynski R, Technau A, Hagen R, Kleinsasser N, Radeloff A, ORL J Otorhinolaryngol Relat Spec 2011 73 9 16 10.1159/000320598 20975314
10. Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. van Buul GM, Kotek G, Wielopolski PA, Farrell E, Bos PK, Weinans H, Grohnert AU, Jahr H, Verhaar JA, Krestin GP, van Osch GJ, Bernsen MR, PLoS One 2011 6 17001 10.1371/journal.pone. 0017001 21373640
11. Superparamagnetic iron oxide nanoparticle labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness. Balakumaran A, Pawelczyk E, Ren J, Sworder B, Chaudhry A, Sabatino M, Stroncek D, Frank JA, Robey PG, PLoS One 2010 5 11462 10.1371/journal.pone.0011462 20628641
12. Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. Kedziorek DA, Kraitchman DL, Methods Mol Med 2010 660 171 183
13. Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Wei H, Ooi TH, Tan G, Lim SY, Qian L, Wong P, Shim W, Heart Fail Rev 2010 15 1 14 10.1007/s10741-009- 9134-1 19238541
14. - 14.1 T whole body MRI for detection of mesoangioblast stem cells in a murine model of Duchenne muscular dystrophy. Odintsov B, Chun JL, Mulligan JA, Berry SE, Magn Reson Med 2011 66 1704 1714 10.1002/mrm.22942 22086733
15. Orthopaedic applications of nanoparticle-based stem cell therapies. Wimpenny I, Markides H, El Haj AJ, Stem Cell Res Ther 2012 3 13 10.1186/scrt104 22520594
16. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS, Yoneda T, MacDonald IC, Chambers AF, Rutt BK, Foster PJ, Magn Reson Med 2006 56 1001 1010 10.1002/mrm.21029 17029229 (Pubitemid 44691342)
17. Magnetically labeled mesenchymal stem cells after autologous transplantation into acutely injured liver. Shi XL, Gu JY, Han B, Xu HY, Fang LA, Ding YT, World J Gastroenterol 2010 16 3674 3679 10.3748/wjg.v16.i29.3674 20677339
18. A molecular MRI probe to detect treatment of cardiac apoptosis in vivo. Dash R, Chung J, Chan T, Yamada M, Barral J, Nishimura D, Yang PC, Simpson PC, Magn Reson Med 2011 66 1152 1162 10.1002/mrm.22876 21360750
19. In vivo evaluation of cerebral transplantation of resovist-labeled bone marrow stromal cells in Parkinson's disease rats using magnetic resonance imaging. Guo J, Shen JK, Wang L, Xiao L, Zhang RJ, Luo WF, Gong ZG, Sun J, Xu H, Sirois P, Li K, Appl Biochem Biotechnol 2011 163 636 648 10.1007/s12010-010- 9069-y 20821072
20. In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticle using 3.0T MRI. Reddy AM, Kwak BK, Shim HJ, Ahn C, Lee HS, Suh YJ, Park ES, J Korean Med Sci 2010 25 211 219 10.3346/jkms.2010.25.2.211 20119572
21. In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats. Yao Y, Li Y, Ma G, Liu N, Ju S, Jin J, Chen Z, Shen C, Teng G, Mol Imaging Biol 2011 13 303 313 10.1007/s11307-010- 0359-0 20552286
22. The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. Kim HS, Oh SY, Joo HJ, Son KR, Song IC, Moon WK, NMR Biomed 2010 23 514 522 10.1002/nbm.1487 20175151
23. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Wang L, Deng J, Wang J, Xiang B, Yang T, Gruwel M, Kashour T, Tomanek B, Summer R, Freed D, Jassal DS, Dai G, Glogowski M, Deslauriers R, Arora RC, Tian G, Magn Reson Imaging 2009 27 108 119 10.1016/j.mri.2008.05.013 18657922
24. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. Rice HE, Hsu EW, Sheng H, Evenson DA, Freemerman AJ, Safford KM, Provenzale JM, Warner DS, Johnson GA, Am J Roentgenol 2007 188 1101 1108 10.2214/AJR.06.0663 (Pubitemid 46496950)
25. Citric-acid-coated magnetite nanoparticles for biological applications. Rǎcuciu M, Creangǎ DE, Airinei A, Eur Phys J E Soft Matter 2006 21 117 121 10.1140/epje/i2006-10051-y 17180642 (Pubitemid 44970437)
26. Mesenchymal stromal cells: past, present, and future. Spencer ND, Gimble JM, Lopez MJ, Vet Surg 2011 40 129 139 10.1111/j.1532-950X.2010.00776.x 21223314
27. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
28. Activation of Sirtl decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. Bäckesjö CM, Li Y, Lindgren U, Haldosén LA, J Bone Miner Res 2006 21 993 1002 10.1359/jbmr.060415 16813520 (Pubitemid 43962828)
29. Cell therapy in myocardial infarction: emphasis on the role of MRI. Ye YX, Bogaert J, Eur Radiol 2008 18 548 569 10.1007/s00330-007-0777-9 17922278 (Pubitemid 351249801)
30. Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles. Suh JS, Lee JY, Choi YS, Yu F, Yang V, Lee SJ, Chung CP, Park YJ, Biochem Biophys Res Commun 2009 379 669 675 10.1016/j.bbrc.2008.12.041 19101509
31. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA, Radiology 2003 229 838 846 10.1148/radiol.2293021215 14657318 (Pubitemid 37467591)
32. Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Wang HH, Wang YX, Leung KC, Au DW, Xuan S, Chak CP, Lee SK, Sheng H, Zhang G, Qin L, Griffith JF, Ahuja AT, Chemistry 2009 15 12417 12425 10.1002/chem.200901548 19834937
33. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JWM, NMR Biomed 2004 17 513 517 10.1002/nbm.925 15526348 (Pubitemid 39549429)
34. The inhibitory effect of superparamagnetic iron oxide nanoparticles (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Chen YC, Hsiao JK, Liu HM, Lai IY, Yao M, Hsu SC, Ko BS, Chen YC, Yang CS, Huang DM, Toxicol Appl Pharmacol 2010 245 272 279 10.1016/j.taap.2010.03.011 20338187
35. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. Pawelezyk E, Arbab AS, Pandit S, Hu E, Frank JA, NMR Biomed 2006 19 581 592 10.1002/nbm.1038 16673357
36. Size-dependent toxicity of metal oxide particles: a comparison between nano- and micrometer size. Karlsson HL, Gustafsson J, Cronholm P, Moller L, Toxicol Lett 2009 188 112 118 10.1016/j.toxlet.2009.03.014 19446243
37. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC, Part Fibre Toxicol 2009 6 1 14 10.1186/1743-8977-6-1 19134195